Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 3
Submit an article Journal homepage
33
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Effects of Topical Ropivacaine on Eicosanoids and Neurotransmitters in the Rectum of Patients with Distal Ulcerative Colitis

J. G. Hillingsø
,
J. Kjeldsen
,
P. T. Schmidt
,
T. N. Rasmussen
,
B. Fischer-Hansen
,
J. J. Holst
,
K. Lauritsen
,
K. Bukhave
&
J. Rask-Madsen
 show all
Pages 325-329 | Published online: 08 Jul 2009

  • Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol 1996;31 Suppl 216:149 -60.
  • Anton PA, Shanahan F. Neuroimmunomodulation in inflammatory bowel disease. How far from "bench" to "bedside" Ann NY Acad Sci 1998;840:723-34.
  • Feinstein MB,Fickers J. Fraser C. An analysis of the mechanism of local anaesthetic inhibition of platelet aggregation and secretion. J Pharmacol Exp Ther 1976;197:215-28.
  • Steward GJ,Antithrombotic activity of local anaesthetics in several canine model. Reg Anaesth 1982;7:89.
  • Chvapil M,Hamersoff SR. O'Dea K. Peacock EE. Local anaesthetics and wound healing. J Surg Res 1979;27:367-71.
  • Cullen BF, Haschke RH. Local anaesthetic inhibition of phagocytosis and metabolism of human leucocytes. Anaesthesiology 1974;40:142-5.
  • Vanderbroucke-Grauls CMJE, Thijssen RMWM. Marcelis JH. Sharma SD. Verhoef J Effcets of lysomotropic amines on human polymorphonuclear leucocyte function. Immunology 1984;51:319-26.
  • MacGregor RR,Thorner RE. Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocytc delivery to inflammatory sites. Blood 1980;56:23-9.
  • Hammer R,Dahlgren C. Stendahl O. lnhibition of human leucocyte metabolism and random motility by local anaesthesia. Acta Anaesthesiol Scand 1985;29:520-3.
  • McCaffery DM, Wallace JL. Sharkey KA. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol 1997;272:G272-80.
  • BjÜrck S,Ahlman H. DahlstÜm A. Lidocaine and ulcerative proctitis. Lancet 1998;1:1330.
  • Björck S,Dahlström A. Ahlman H. Topical treatment of ulcerative proctitis with lidocaine. Scand J Gastroenterol 1989;24:1061-72.
  • Jacobsen BA, Rasmussen SN. Lidocaine gel treatment for refractory distal ulcerative colitis. Gut 1994;355:A122.
  • Arlander E., Ost A. Stahlberg D. Löfberg R. Ropivacaine gel in distal ulcerative colitis and proctitis -- a pharmacokinetic and exploratory clinical study. Aliment Pharmacol Ther 1996;10:73 81.
  • Binder V, Both H. Hansen PK. Hendriksen C. Kreiner S. TorpPedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the county of Copenhagen. 1962 to 1978. Gastroenterology 1982;83:563-8.
  • Powell-Tuck J, Brown RL. Lennard-Jones JE. A comparison of oral prednisolone given as a single and multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978;13:833-7.
  • Lauritsen K, Laursen LS. Bukhave K, Rask-Madsen J. Effects of topical 5- amino-salicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing; ulcerative colitis. Gastroenterology 1986;91:837-44.
  • Lauritsen K, Laursen LS, Bokhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis. Crohn's colitis. and Clastridium difficile colitis, Gastroenterology 1988;95:11-7.
  • Bukhave K. Rask-Madsen J. Prostaglandin E2 in jejunal fluids and its potential diagnostic value for selecting patients with indomethacio-sensitive diarrhoea Eur J Clin Invest 1981;11:191-7.
  • Bukhave K, Green K. Rask-Madsen J. Comparison of radioimmunological determination with gas chromolography massspectometry dosage. A study of PGE2 and PGF2 in gastrointestinal fluids. Biomed Mass Spectrom 1983;10:265-8.
  • Holst JJ, Bersani M. Assays for peptide products of somatostatin gene expression. In: Conn PM, editor. Methods in neurosciences: neuropeptide technology. San Diego: Academic Press: 1991;5:3 21.
  • Schmidt P, Poulsen SS. Rasmussen TR. Bersani M. Holst JJ. Substance P and neurokinin A are co-distributed and co-localized in the porcine gastrointestinal tract. Peptides 1991;12:963-73.
  • Hilsted L. Holst JJ. On the accuracy of radioimmunological determination of somatostatin in plasma Regul Pept 1982;4:13-31.
  • Fahrenkrug J,Schaffalitzky de Muckadel OB. Radioimmunoassay say of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med 1977;89:1379-88.
  • Rasmussen TN,Bersani M. Johnsen AH. Kofod H, Holst JJ. Pigs only produce a single form of CGRP part of which is processed to N-and C-terminal fragments. Peptides 1994;15:89-94.
  • Martinsson T, Haegerstrand A. Dalsgaard CJ. Effects of ropivacaine on cicosanoid release from human granulocytes and endothelial cells in vitro. lnflamm Res 1997;46:398-403
  • Payan DG. Neuropeptides and inflammation: the role of substance P. Ann Rev Med 1989;40:341-52.
  • Koch TR, Carney JA. Go VLW. Distribution and quantization of gut neuropeptides in normal intestine and inflammatory bowel disease. Dig Dis Sci 1987;32:369-76.
  • Goldin E, Karmeli F, Selinger Z, Rachmiclewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989;34:754-7.
  • Bernstein CN. Robert ME. Eysselein VE. Rectal substance P concentrations are increased in ulcerativc colitis but not in Crohn's disease. Am J Gastroenterol 1993;88:909-13.
  • Yamamoto H, Morise K, Kusugami K Furusawa A. Konagaya T. Nishio Y. et al. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease. J Gastroenterol 1996;31:525-32.
  • Calam J. Ghatei MA. Domin J, Adrian TE. Myszor M. Gupta S, et al. Regional differences in concentrations of regulatory peptides. In human colon mucosal biopsy. Dig Dis Sci 1989;34:1193-8.
  • O'Morain C,Bishop AE, McGregor GP. Levi AJ. Bloom SR. Polak JM, et al. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut 1984;25:57-61.
  • Bishop A, Polak JM, Bryant MG. Bloom SR. Hamilton S. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 1980;79:853-60.
  • Koch TR. Carney JA. Morris VA. Go VLW. Somalostatin in the idiopathic inflammatory bowel diseases. Dis Colon Rectum 1988;31:198-203.
  • Eysselein VE. Reinshagen M. Patel A. Davis W. Nast C. Sternini C. Calcitonin gene-related peptide in inflammatory bowel disease and experimentally induced colitis. Ann NY Acad Sci 1992;657:319-27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.